Cytek biosciences earnings call

WebFeb 28, 2024 · Cytek Biosciences, Inc. provided revenue guidance for the full year 2024. For the year, the company expects revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This includes approximately $20 million of revenue contribution from the acquisition of Luminex's Flow Cytometry and … WebNov 8, 2024 · Cytek Biosciences, Inc. (NASDAQ:CTKB) Q3 2024 Earnings Conference Call November 8, 2024 4:30 PM ET. Company Participants. Wenbin Jiang - Chief …

Cytek Biosciences Reports Fourth Quarter and Full Year 2024 …

WebAug 10, 2024 · Cytek Biosciences, Inc. , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $40.16 million for the quarter ended June 2024, missing the Zacks Consensus... WebIn the wake of Cytek Biosciences, Inc.'s (NASDAQ:CTKB) latest US$70m market cap drop, institutional owners may be forced to take severe actions. Simply Wall St. Sep-07-22 01:27AM. RGAIA Investment: Cytek Biosciences (CTKB) is Profitable Today & Will be Even More So in the Future. Insider Monkey +5.29%. simply ming 1800w induction burner https://pixelmv.com

Cytek Biosciences Reports Fourth Quarter and Full Year 2024

WebApr 10, 2024 · About the company. Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence … WebNov 9, 2024 · Sector news Transcript : Cytek Biosciences, Inc., Q3 2024 Earnings Call, Nov 09, 2024 11/09/2024 04:30pm EDT Welcome to Cytek's Third Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator... WebFeb 28, 2024 · Cytek Biosciences, Inc., which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $48.34 million for the quarter ended December 2024, missing the Zacks... raytheon technologies stock outlook

Bio-Rad Laboratories, Inc. : RBC Capital Markets da una …

Category:EarningsCall · Cytek Biosciences, Inc.

Tags:Cytek biosciences earnings call

Cytek biosciences earnings call

Investor Relations Cytek Biosciences

Webwww.cytekbio.com Ownership Status Publicly Held Financing Status Formerly VC-backed Primary Industry Other Devices and Supplies Other Industries Other Healthcare Technology Systems Biotechnology Stock Exchange NAS Primary Office 46107 Landing Parkway Fremont, CA 94538-6407 United States +1 (877) 000-0000 Cytek Timeline 2024 2024 … WebFeb 28, 2024 · Other than Cytek’s Northern Lights CLC system, which is available for clinical use in China and the European Union, Cytek’s products are for research use only – not for use in diagnostic procedures. Stock Information $8.75 NASDAQ GS: CTKB 0 … The Investor Relations website contains information about Cytek Biosciences's … Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from … Mar 24, 2024: 144: Filed by "insiders" prior intended sale of restricted stock. Non … Cytek Biosciences Fourth Quarter and Full Year 2024 Earnings Conference Call. … Cytek Biosciences, CEO. Wenbin Jiang, Ph.D. has served as Cytek’s Chief … The Investor Relations website contains information about Cytek Biosciences's … Cytek was incorporated in Delaware in 2014 under the name Cytoville, Inc. In August …

Cytek biosciences earnings call

Did you know?

WebFeb 24, 2024 · Cytek Biosciences, Inc. (NASDAQ:NASDAQ:CTKB) Q4 2024 Earnings Conference Call February 23, 2024 5:00 PM ETCompany ParticipantsAlex Khan - … WebMay 11, 2024 · Presentation Operator MessageOperator Thank you for standing by, and welcome to the Cytek Biosciences First Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, today's... April 12, 2024

WebNov 9, 2024 · Sector news Transcript : Cytek Biosciences, Inc., Q3 2024 Earnings Call, Nov 09, 2024 11/09/2024 04:30pm EDT Welcome to Cytek's Third Quarter 2024 … WebApr 13, 2024 · RBC Capital Markets is positief over het aandeel met een koopadvies. Voorheen was het koersdoel 579 USD, maar deze is licht aangepast naar 582 USD. 13 april 2024

WebFeb 6, 2024 · Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 28, 2024. Feb 07, 2024. WebApr 5, 2024 · CYTEK BIOSCIENCES, INC. company earnings calendar and analyst expectations - Upcoming and past events Nasdaq: CTKB Nasdaq. ... Acquisition of Flow Cytometry & Imaging Business From DiaSorin By Cytek Biosciences, Inc Call: 12/01/22 08:30am : Piper Sandler Healthcare Conference - Fireside chat: 11/09/22 06:50pm :

WebApr 12, 2024 · CTKB Cytek Biosciences, Inc. Earnings Call Transcripts 451 followers $9.19 0.28 ( +3.14%) 4:00 PM 03/31/23 NASDAQ $USD Market Close Summary …

WebFeb 23, 2024 · Cytek Biosciences expects full year 2024 revenue to be in the range of $160 million to $168 million. Webcast Information Cytek will host a conference call to discuss the fourth quarter 2024 financial results on Wednesday, February 23, 2024, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. raytheon technologies stock dividend historyWebApr 10, 2024 · Cytek Biosciences, Inc. is a cell analysis solutions company. The Company offers cell analysis tools by leveraging technical approaches. Its instruments, the Aurora and Northern Lights systems, are the spectrum flow cytometers able to deliver cell analysis by utilizing the spectrum of fluorescence signatures from multiple lasers to distinguish … simply ming air fryerWebApr 13, 2024 · Búsqueda avanzada Conéctate. ¿Olvidó su contraseña? raytheon technologies stock price marketwatchWebMar 1, 2024 · Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of 40% and 3.07%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? raytheon technologies stock price chartWebFeb 28, 2024 · Provides full year 2024 revenue guidance of $225 million to $235 million, or growth of 37% to 43% over full year 2024. FREMONT, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) ( Nasdaq: CTKB) today reported financial results for the fourth quarter and year ended December … raytheon technologies stock dividendsWebAug 10, 2024 · Q2 2024 Cytek Biosciences Inc Earnings Call Sep 21, 2024 (Thomson StreetEvents) -- Edited Transcript of Cytek Biosciences Inc earnings conference call … raytheon technologies stock price historyWebResearch tools you need to invest in the public markets. We make listening to earnings calls easy. simply ming air fryer directions